Table 1
Summary of patient’s diagnosis, treatment, and outcome.
| Patient | Age | Gender | Preop state | Bacteriology | Antibiotic in spacer | IV antibiotics | Oral antibiotics | AR | LEFS | Infection eradication |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 75 | Male | Inf TKA | MRSA | Vancomycin 6 g | Linezolid 600 mg b.d. 6 wk | No | No | 41.3% | Failed* |
| 2 | 67 | Female | Inf TKA | Not detected | Vancomycin 3 g + Imipenem 2 g | Imipenem 500 mg b.d. 4 wk | Cefuroxime 6 wk | Yes | 60.0% | Yes |
| 3 | 85 | Male | Inf PHA | MRSA | Vancomycin 6 g | Vancomycin 1g b.d. 6 wk | Forlen 6 wk | No | N/A | Yes |
Preop = preoperative; IV = intravenous; Inf = infected; TKA = total knee arthroplasty; MRSA = methicillin-resistant Staphylococcus aureus; AR = arthroplasty revision; LEFS = Lower Extremity Functional Scale; N/A: not available.
* Spacer exchange within three months, infection eradicated later.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.